drugset / Trial / NCT00036127

Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

NCT00036127

Treatment

Summary

Study to learn if the alternate formulation is effective in agitated schizophrenic patients

Timeline

Start
2002-04
Primary completion
2003-01
Completion
2003-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 1 mg Intramuscular
Subject Aripiprazole Other / unclassified 5.25 mg Intramuscular
Subject Aripiprazole Other / unclassified 9.75 mg Intramuscular
Subject Aripiprazole Other / unclassified 15 mg Intramuscular

Indications